These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 35815345)
1. Biallelic variants in WARS1 cause a highly variable neurodevelopmental syndrome and implicate a critical exon for normal auditory function. Lin SJ; Vona B; Porter HM; Izadi M; Huang K; Lacassie Y; Rosenfeld JA; Khan S; Petree C; Ali TA; Muhammad N; Khan SA; Muhammad N; Liu P; Haymon ML; Rüschendorf F; Kong IK; Schnapp L; Shur N; Chorich L; Layman L; Haaf T; Pourkarimi E; Kim HG; Varshney GK Hum Mutat; 2022 Oct; 43(10):1472-1489. PubMed ID: 35815345 [TBL] [Abstract][Full Text] [Related]
2. WARS1 and SARS1: Two tRNA synthetases implicated in autosomal recessive microcephaly. Bögershausen N; Krawczyk HE; Jamra RA; Lin SJ; Yigit G; Hüning I; Polo AM; Vona B; Huang K; Schmidt J; Altmüller J; Luppe J; Platzer K; Dörgeloh BB; Busche A; Biskup S; Mendes MI; Smith DEC; Salomons GS; Zibat A; Bültmann E; Nürnberg P; Spielmann M; Lemke JR; Li Y; Zenker M; Varshney GK; Hillen HS; Kratz CP; Wollnik B Hum Mutat; 2022 Oct; 43(10):1454-1471. PubMed ID: 35790048 [TBL] [Abstract][Full Text] [Related]
3. Four pedigrees with aminoacyl-tRNA synthetase abnormalities. Okamoto N; Miya F; Tsunoda T; Kanemura Y; Saitoh S; Kato M; Yanagi K; Kaname T; Kosaki K Neurol Sci; 2022 Apr; 43(4):2765-2774. PubMed ID: 34585293 [TBL] [Abstract][Full Text] [Related]
4. Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and Nails. Kuo ME; Theil AF; Kievit A; Malicdan MC; Introne WJ; Christian T; Verheijen FW; Smith DEC; Mendes MI; Hussaarts-Odijk L; van der Meijden E; van Slegtenhorst M; Wilke M; Vermeulen W; Raams A; Groden C; Shimada S; Meyer-Schuman R; Hou YM; Gahl WA; Antonellis A; Salomons GS; Mancini GMS Am J Hum Genet; 2019 Mar; 104(3):520-529. PubMed ID: 30824121 [TBL] [Abstract][Full Text] [Related]
5. Variants of aminoacyl-tRNA synthetase genes in Charcot-Marie-Tooth disease: A Korean cohort study. Nam DE; Park JH; Park CE; Jung NY; Nam SH; Kwon HM; Kim HS; Kim SB; Son WS; Choi BO; Chung KW J Peripher Nerv Syst; 2022 Mar; 27(1):38-49. PubMed ID: 34813128 [TBL] [Abstract][Full Text] [Related]
6. Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities. Weterman MAJ; Kuo M; Kenter SB; Gordillo S; Karjosukarso DW; Takase R; Bronk M; Oprescu S; van Ruissen F; Witteveen RJW; Bienfait HME; Breuning M; Verhamme C; Hou YM; de Visser M; Antonellis A; Baas F Hum Mol Genet; 2018 Dec; 27(23):4036-4050. PubMed ID: 30124830 [TBL] [Abstract][Full Text] [Related]
7. MARS variant associated with both recessive interstitial lung and liver disease and dominant Charcot-Marie-Tooth disease. Rips J; Meyer-Schuman R; Breuer O; Tsabari R; Shaag A; Revel-Vilk S; Reif S; Elpeleg O; Antonellis A; Harel T Eur J Med Genet; 2018 Oct; 61(10):616-620. PubMed ID: 29655802 [TBL] [Abstract][Full Text] [Related]
8. Predicting the pathogenicity of aminoacyl-tRNA synthetase mutations. Oprescu SN; Griffin LB; Beg AA; Antonellis A Methods; 2017 Jan; 113():139-151. PubMed ID: 27876679 [TBL] [Abstract][Full Text] [Related]
9. A missense, loss-of-function Forrest ME; Meyer AP; Laureano Figueroa SM; Antonellis A Cold Spring Harb Mol Case Stud; 2022 Dec; 8(7):. PubMed ID: 36307205 [TBL] [Abstract][Full Text] [Related]
10. Neurodegenerative Charcot-Marie-Tooth disease as a case study to decipher novel functions of aminoacyl-tRNA synthetases. Wei N; Zhang Q; Yang XL J Biol Chem; 2019 Apr; 294(14):5321-5339. PubMed ID: 30643024 [TBL] [Abstract][Full Text] [Related]
11. To charge or not to charge: mechanistic insights into neuropathy-associated tRNA synthetase mutations. Wallen RC; Antonellis A Curr Opin Genet Dev; 2013 Jun; 23(3):302-9. PubMed ID: 23465884 [TBL] [Abstract][Full Text] [Related]
12. De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects. Manole A; Efthymiou S; O'Connor E; Mendes MI; Jennings M; Maroofian R; Davagnanam I; Mankad K; Lopez MR; Salpietro V; Harripaul R; Badalato L; Walia J; Francklyn CS; Athanasiou-Fragkouli A; Sullivan R; Desai S; Baranano K; Zafar F; Rana N; Ilyas M; Horga A; Kara M; Mattioli F; Goldenberg A; Griffin H; Piton A; Henderson LB; Kara B; Aslanger AD; Raaphorst J; Pfundt R; Portier R; Shinawi M; Kirby A; Christensen KM; Wang L; Rosti RO; Paracha SA; Sarwar MT; Jenkins D; ; Ahmed J; Santoni FA; Ranza E; Iwaszkiewicz J; Cytrynbaum C; Weksberg R; Wentzensen IM; Guillen Sacoto MJ; Si Y; Telegrafi A; Andrews MV; Baldridge D; Gabriel H; Mohr J; Oehl-Jaschkowitz B; Debard S; Senger B; Fischer F; van Ravenwaaij C; Fock AJM; Stevens SJC; Bähler J; Nasar A; Mantovani JF; Manzur A; Sarkozy A; Smith DEC; Salomons GS; Ahmed ZM; Riazuddin S; Riazuddin S; Usmani MA; Seibt A; Ansar M; Antonarakis SE; Vincent JB; Ayub M; Grimmel M; Jelsig AM; Hjortshøj TD; Karstensen HG; Hummel M; Haack TB; Jamshidi Y; Distelmaier F; Horvath R; Gleeson JG; Becker H; Mandel JL; Koolen DA; Houlden H Am J Hum Genet; 2020 Aug; 107(2):311-324. PubMed ID: 32738225 [TBL] [Abstract][Full Text] [Related]
13. Compound heterozygosity for loss-of-function GARS variants results in a multisystem developmental syndrome that includes severe growth retardation. Oprescu SN; Chepa-Lotrea X; Takase R; Golas G; Markello TC; Adams DR; Toro C; Gropman AL; Hou YM; Malicdan MCV; Gahl WA; Tifft CJ; Antonellis A Hum Mutat; 2017 Oct; 38(10):1412-1420. PubMed ID: 28675565 [TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and proteome modifications in two Charcot-Marie-Tooth families with the AARS1 Arg326Trp mutation. Høyer H; Busk ØL; Esbensen QY; Røsby O; Hilmarsen HT; Russell MB; Nyman TA; Braathen GJ; Nilsen HL BMC Neurol; 2022 Aug; 22(1):299. PubMed ID: 35971119 [TBL] [Abstract][Full Text] [Related]
16. Biallelic KARS pathogenic variants cause an early-onset progressive leukodystrophy. Itoh M; Dai H; Horike SI; Gonzalez J; Kitami Y; Meguro-Horike M; Kuki I; Shimakawa S; Yoshinaga H; Ota Y; Okazaki T; Maegaki Y; Nabatame S; Okazaki S; Kawawaki H; Ueno N; Goto YI; Kato Y Brain; 2019 Mar; 142(3):560-573. PubMed ID: 30715177 [TBL] [Abstract][Full Text] [Related]
17. Biallelic mutations in valyl-tRNA synthetase gene VARS are associated with a progressive neurodevelopmental epileptic encephalopathy. Friedman J; Smith DE; Issa MY; Stanley V; Wang R; Mendes MI; Wright MS; Wigby K; Hildreth A; Crawford JR; Koehler AE; Chowdhury S; Nahas S; Zhai L; Xu Z; Lo WS; James KN; Musaev D; Accogli A; Guerrero K; Tran LT; Omar TEI; Ben-Omran T; Dimmock D; Kingsmore SF; Salomons GS; Zaki MS; Bernard G; Gleeson JG Nat Commun; 2019 Feb; 10(1):707. PubMed ID: 30755602 [TBL] [Abstract][Full Text] [Related]
18. Aminoacyl-tRNA synthetases in Charcot-Marie-Tooth disease: A gain or a loss? Zhang H; Zhou ZW; Sun L J Neurochem; 2021 May; 157(3):351-369. PubMed ID: 33236345 [TBL] [Abstract][Full Text] [Related]
19. Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland. Bansagi B; Antoniadi T; Burton-Jones S; Murphy SM; McHugh J; Alexander M; Wells R; Davies J; Hilton-Jones D; Lochmüller H; Chinnery P; Horvath R J Neurol; 2015 Aug; 262(8):1899-908. PubMed ID: 26032230 [TBL] [Abstract][Full Text] [Related]
20. Tryptophan-dependent and -independent secretions of tryptophanyl- tRNA synthetase mediate innate inflammatory responses. Nguyen TTT; Choi YH; Lee WK; Ji Y; Chun E; Kim YH; Lee JE; Jung HS; Suh JH; Kim S; Jin M Cell Rep; 2023 Jan; 42(1):111905. PubMed ID: 36640342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]